190 related articles for article (PubMed ID: 12756158)
21. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study.
Engström G; Hedblad B; Stavenow L; Tydén P; Lind P; Janzon L; Lindgärde F
Circulation; 2004 Jul; 110(1):27-31. PubMed ID: 15210605
[TBL] [Abstract][Full Text] [Related]
22. Coffee consumption and coronary heart disease in men and women: a prospective cohort study.
Lopez-Garcia E; van Dam RM; Willett WC; Rimm EB; Manson JE; Stampfer MJ; Rexrode KM; Hu FB
Circulation; 2006 May; 113(17):2045-53. PubMed ID: 16636169
[TBL] [Abstract][Full Text] [Related]
23. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998.
Ladwig KH; Marten-Mittag B; Löwel H; Döring A; Koenig W;
Eur Heart J; 2005 Dec; 26(23):2537-42. PubMed ID: 16126719
[TBL] [Abstract][Full Text] [Related]
25. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
26. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study.
Astor BC; Coresh J; Heiss G; Pettitt D; Sarnak MJ
Am Heart J; 2006 Feb; 151(2):492-500. PubMed ID: 16442920
[TBL] [Abstract][Full Text] [Related]
27. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
Chiuve SE; McCullough ML; Sacks FM; Rimm EB
Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
[TBL] [Abstract][Full Text] [Related]
28. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease.
Albert CM; Oh K; Whang W; Manson JE; Chae CU; Stampfer MJ; Willett WC; Hu FB
Circulation; 2005 Nov; 112(21):3232-8. PubMed ID: 16301356
[TBL] [Abstract][Full Text] [Related]
29. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
Albert CM; Chae CU; Rexrode KM; Manson JE; Kawachi I
Circulation; 2005 Feb; 111(4):480-7. PubMed ID: 15687137
[TBL] [Abstract][Full Text] [Related]
30. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan.
Li WF; Sun CW; Cheng TJ; Chang KH; Chen CJ; Wang SL
Toxicol Appl Pharmacol; 2009 Apr; 236(2):246-53. PubMed ID: 19371607
[TBL] [Abstract][Full Text] [Related]
31. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
[TBL] [Abstract][Full Text] [Related]
32. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
[TBL] [Abstract][Full Text] [Related]
33. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
Lu C; Gao Y; Zhou H; Tian H
Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Mackness B; Davies GK; Turkie W; Lee E; Roberts DH; Hill E; Roberts C; Durrington PN; Mackness MI
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1451-7. PubMed ID: 11557671
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.
Wang M; Lang X; Cui S; Zou L; Cao J; Wang S; Wu X
DNA Cell Biol; 2012 Jun; 31(6):975-82. PubMed ID: 22320866
[TBL] [Abstract][Full Text] [Related]
36. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease.
MacKness B; Mackness MI; Durrington PN; Arrol S; Evans AE; McMaster D; Ferrières J; Ruidavets JB; Williams NR; Howard AN
Eur J Clin Invest; 2000 Jan; 30(1):4-10. PubMed ID: 10619995
[TBL] [Abstract][Full Text] [Related]
37. Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies.
Zhao Y; Ma Y; Fang Y; Liu L; Wu S; Fu D; Wang X
Mol Genet Metab; 2012 Jan; 105(1):141-8. PubMed ID: 22030099
[TBL] [Abstract][Full Text] [Related]
38. High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study.
Yu S; Yarnell JW; Sweetnam P; Bolton CH
Atherosclerosis; 2003 Feb; 166(2):331-8. PubMed ID: 12535746
[TBL] [Abstract][Full Text] [Related]
39. High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.
Mackness B; Hine D; McElduff P; Mackness M
Atherosclerosis; 2006 Jun; 186(2):396-401. PubMed ID: 16140307
[TBL] [Abstract][Full Text] [Related]
40. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins.
Karakaya A; Ibiş S; Kural T; Köse SK; Karakaya AE
Chem Biol Interact; 1999 Apr; 118(3):193-200. PubMed ID: 10362226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
